Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
出版年份 2013 全文链接
标题
Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
作者
关键词
-
出版物
Nutrients
Volume 5, Issue 3, Pages 928-948
出版商
MDPI AG
发表日期
2013-03-19
DOI
10.3390/nu5030928
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans
- (2013) Surabhi Bhutani et al. Obesity
- Drug Treatment of Obesity in Cardiovascular Disease
- (2012) Marietta Charakida et al. American Journal of Cardiovascular Drugs
- Do we need anti-obesity drugs?
- (2012) Vojtěch Hainer et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
- (2012) Ioanna Gouni-Berthold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome
- (2012) A. P. Agouridis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- High-density lipoprotein subclasses and their relationship to cardiovascular disease
- (2012) H. Robert Superko et al. Journal of Clinical Lipidology
- Extended-Release Niacin/Laropiprant Effects on Lipoprotein Subfractions in Patients with Type 2 Diabetes Mellitus
- (2012) Harold Bays et al. Metabolic Syndrome and Related Disorders
- Effect of Anti-Obesity Drug on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2012) Yu-Hao Zhou et al. PLoS One
- Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
- (2012) Aneta Otocka-Kmiecik et al. PROGRESS IN LIPID RESEARCH
- The Effect of Exercise on the Cardiovascular Risk Factors Constituting the Metabolic Syndrome
- (2012) Nele Pattyn et al. SPORTS MEDICINE
- Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol
- (2012) Kaori Hosoyamada et al. Diabetology & Metabolic Syndrome
- Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: ‘A new kid on the block’?
- (2011) Niki Katsiki et al. ANNALS OF MEDICINE
- Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk1
- (2011) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size
- (2011) Hideo Makimura et al. CLINICAL ENDOCRINOLOGY
- Metabolic and functional relevance of HDL subspecies
- (2011) Bela F Asztalos et al. CURRENT OPINION IN LIPIDOLOGY
- Editorial [Hot Topic: New Developments in the Prevention and Treatment of Vascular Disease - 2 Executive (Guest Editors: Manfredi Rizzo and Dimitri P. Mikhailidis)]
- (2011) Manfredi Rizzo et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
- (2011) Alexandros D. Tselepis et al. CURRENT PHARMACEUTICAL DESIGN
- Definition of Postprandial Lipaemia
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects:A Meta-Analysis
- (2011) Constantinos Mihas et al. Current Vascular Pharmacology
- “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Fenofibrate
- (2011) Kate McKeage et al. DRUGS
- Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?
- (2011) Manfredi Rizzo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Low-Density Lipoprotein Sub-Fraction Profiles in Obese Children Before and After Attending a Residential Weight Loss Intervention
- (2011) Roderick FGJ King et al. Journal of Atherosclerosis and Thrombosis
- Small LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis
- (2011) Shinji Koba et al. Journal of Atherosclerosis and Thrombosis
- Effects of Atorvastatin on Nuclear Magnetic Resonance-Defined Lipoprotein Subclasses and Inflammatory Markers in Patients with Hypercholesterolemia
- (2011) Katsunori Ikewaki et al. Journal of Atherosclerosis and Thrombosis
- Influence of Fatty Liver on Plasma Small, Dense LDL- Cholesterol in Subjects with and without Metabolic Syndrome
- (2011) Ikumi Sugino et al. Journal of Atherosclerosis and Thrombosis
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
- (2011) Christie Ballantyne et al. Journal of Clinical Lipidology
- Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome
- (2011) Y K Kim et al. JOURNAL OF HUMAN HYPERTENSION
- Pro-atherogenic postprandial profile: Meal-induced changes of lipoprotein sub-fractions and inflammation markers in obese boys
- (2011) C. Maffeis et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Cardiovascular benefits of bariatric surgery in morbidly obese patients
- (2011) V. G. Athyros et al. Obesity Reviews
- Evolution of Lipid Profiles after Bariatric Surgery
- (2011) Ignacio Garcia-Marirrodriga et al. OBESITY SURGERY
- Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases
- (2011) Hana Rosolova et al. EPMA Journal
- Effects of Rosiglitazone on Fasting and Postprandial Low- and High-Density Lipoproteins Size and Subclasses in Type 2 Diabetes
- (2010) Manfredi Rizzo et al. ANGIOLOGY
- Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults
- (2010) Krista A. Varady et al. BRITISH JOURNAL OF NUTRITION
- Lipoprotein subfractions and cardiovascular disease risk
- (2010) Ronald M Krauss CURRENT OPINION IN LIPIDOLOGY
- High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
- (2010) Laura Calabresi et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
- (2010) Matilda Florentin et al. Current Vascular Pharmacology
- Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
- (2010) Corby K. Martin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of a reduced carbohydrate and reduced fat diet for LDL, HDL, and VLDL subclasses during 9-months of weight maintenance subsequent to weight loss
- (2010) James D LeCheminant et al. Lipids in Health and Disease
- Ethnic differences in serum lipoproteins and their determinants in South African women
- (2010) Julia H. Goedecke et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The effect of ınsulin resistance and obesity on low-density lipoprotein particle size in children
- (2010) Mehmet Emre Taşçılar Journal of Clinical Research in Pediatric Endocrinology
- Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults
- (2009) Krista A Varady et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- LDL and HDL subclasses in acute ischemic stroke: Prediction of risk and short-term mortality
- (2009) Aleksandra Zeljkovic et al. ATHEROSCLEROSIS
- Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
- (2009) Vasilios Athyros et al. CURRENT DRUG TARGETS
- Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype
- (2009) M. Rizzo et al. HUMAN REPRODUCTION
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug-induced fibrotic valvular heart disease
- (2009) Sanjeev Bhattacharyya et al. LANCET
- Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity
- (2009) M.B. Bos et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Reversal of Small, Dense LDL Subclass Phenotype by Normalization of Adiposity
- (2009) Patty W. Siri-Tarino et al. Obesity
- Atherogenic dyslipidemia and oxidative stress: a new look
- (2009) Manfredi Rizzo et al. Translational Research
- Effect of Combination Nicotinic Acid and Gemfibrozil Treatment on Intermediate Density Lipoprotein, and Subclasses of Low Density Lipoprotein and High Density Lipoprotein in Patients With Combined Hyperlipidemia
- (2008) H. Robert Superko et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Small Dense LDL-Cholesterol Relative to LDL-Cholesterol is a Strong Independent Determinant of Hypoadiponectinemia in Metabolic Syndrome
- (2008) Noriko Satoh et al. CIRCULATION JOURNAL
- Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome
- (2008) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Is it LDL particle size or number that correlates with risk for cardiovascular disease?
- (2008) H. Robert Superko et al. Current Atherosclerosis Reports
- The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia
- (2008) E. S. Nakou et al. CURRENT MEDICAL RESEARCH AND OPINION
- Multiple actions of high-density lipoprotein
- (2008) Matilda Florentin et al. CURRENT OPINION IN CARDIOLOGY
- Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes
- (2008) M. Rizzo et al. DIABETIC MEDICINE
- The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia
- (2008) ES Nakou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
- (2008) Kaspar Berneis et al. EXPERT OPINION ON PHARMACOTHERAPY
- LDL size and subclasses in patients with abdominal aortic aneurysm
- (2008) Manfredi Rizzo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
- (2008) K. Berneis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women
- (2008) F Magkos et al. INTERNATIONAL JOURNAL OF OBESITY
- Lipoprotein Management in Patients With Cardiometabolic Risk
- (2008) John D. Brunzell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome
- (2008) K. G. Lagos et al. LIPIDS
- Bariatric Surgery Improves Atherogenic LDL Profile by Triglyceride Reduction
- (2008) Sabina Zambon et al. OBESITY SURGERY
- Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy
- (2008) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Comparison of the effects of four commercially available weight-loss programmes on lipid-based cardiovascular risk factors
- (2008) LM Morgan et al. PUBLIC HEALTH NUTRITION
- Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity
- (2007) Juliana A. de Souza et al. ATHEROSCLEROSIS
- Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
- (2007) Manfredi Rizzo et al. ATHEROSCLEROSIS
- The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome
- (2007) T. D. Filippatos et al. DIABETES OBESITY & METABOLISM
- Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women
- (2007) T. Tzotzas et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started